Science Explorer Interactive view Map
Company · Barcelona · Spain

Otsuka Pharmaceutical (Spain)

In research, Otsuka Pharmaceutical (Spain) stands highest in Medicine (#7,755 of 17,978 worldwide), Health Sciences (#10,365 of 20,462 worldwide) and Life Sciences (#8,880 of 14,347 worldwide), over all time.

otsuka-europe.com/es/homeROR OpenAlex
World rank, 2022–2025
#23,494
of 28,054 · #18,024 all time
Rank in Spain
#583
of 658
Research works
523
▲ 8% vs 2013–17
Citations
12k
23.3 per fractional work
Top-10% rate
11.8%
record average 16.5%
Open access
60%
world 28%

What is Otsuka Pharmaceutical (Spain) known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
MedicineField #7,755 of 17,978 11.4%264
Health SciencesDomain #10,365 of 20,462 11.1%288
Life SciencesDomain #8,880 of 14,347 13.8%150

Each strip is that field’s whole ranked pool, with the notch where Otsuka Pharmaceutical (Spain) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.48× its world share, 2 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 1.17× its world share, 5 worksBiochemistry, Geneti…Immunology and Microbiology: 1.66× its world share, 1 worksImmunology and Micro…Neuroscience: 2.06× its world share, 2 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 7.01× its world share, 2 worksPharmacology, Toxico…Chemistry: 0.56× its world share, 1 worksChemistryComputer Science: 0.24× its world share, 1 worksComputer ScienceEngineering: 0.09× its world share, 1 worksEngineeringMaterials Science: 0.16× its world share, 0 worksMaterials ScienceMathematics: 0.64× its world share, 1 worksMathematicsDentistry: 0.23× its world share, 0 worksDentistryHealth Professions: 1.58× its world share, 3 worksHealth ProfessionsMedicine: 2.60× its world share, 37 worksMedicineNursing: 5.35× its world share, 2 worksNursingArts and Humanities: 0.31× its world share, 1 worksArts and HumanitiesBusiness, Management and Accounting: 1.00× its world share, 2 worksBusiness, Management…Decision Sciences: 2.19× its world share, 2 worksDecision SciencesEconomics, Econometrics and Finance: 2.67× its world share, 4 worksEconomics, Econometr…Psychology: 2.09× its world share, 5 worksPsychologySocial Sciences: 0.28× its world share, 3 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 7.0×. Every wedge is a field page.

Who are the top researchers at Otsuka Pharmaceutical (Spain)?

Ranked on the composite score, Masuhiro Nishimura lead among researchers whose main affiliation is Otsuka Pharmaceutical (Spain).

  1. 1 Masuhiro Nishimura Spain · #816,843 worldwide 36 citations · 20 works
All ranked researchers at Otsuka Pharmaceutical (Spain)

Which keywords describe research at Otsuka Pharmaceutical (Spain)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Metabolic Syndrome, Quality of Life, Treatment, Inflammation, Cost-effectiveness Analysis, Health Utility Measures, Prevalence and Genetics.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Quality of Life5▲ 4.9×12 topics
  2. Inflammation5▲ 3.2×21 topics
  3. Treatment5▲ 5.2×19 topics
  4. Epidemiology5▲ 1.58×34 topics
  5. Metabolic Syndrome4▲ 7.3×7 topics
  6. Genetics3▲ 6.2×9 topics
  7. Cost-effectiveness Analysis3▲ 51×1 topic
  8. Health Utility Measures3▲ 51×1 topic
  9. Prevalence3▲ 10×4 topics
  10. Depression3▲ 4.6×13 topics
  11. Diagnosis3▲ 4.2×13 topics
  12. Cognitive Therapy3▲ 35×2 topics
  13. Neurobiology3▲ 15×6 topics
  14. Aging3▲ 6.7×7 topics
  15. Antipsychotic Drugs3▲ 93×1 topic
  16. Neurocognitive Deficits3▲ 93×1 topic
  17. Cardiovascular Disease2▲ 3.0×9 topics
  18. Alzheimer's Disease2▲ 11×3 topics
  19. Clinical Trials2▲ 4.8×9 topics
  20. Critical Care2▲ 13×4 topics
  21. Neurological Disorders2▲ 5.2×6 topics
  22. Anxiety2▲ 5.9×9 topics
  23. Meta-Analysis2▲ 4.7×7 topics
  24. Biomarkers2▲ 3.9×8 topics
  25. Neuroimaging2▲ 9.9×3 topics
  26. Brain Imaging2▲ 33×2 topics
  27. Adverse Drug Reactions2▲ 46×3 topics
  28. Caregiver Burden2▲ 20×2 topics
  29. ADHD2▲ 59×1 topic
  30. Attention-Deficit/Hyperactivity Disorder2▲ 59×1 topic
  31. Cognitive Decline2▲ 18×2 topics
  32. Heart Failure2▲ 5.0×4 topics
  33. Business Ethics2▲ 25×2 topics
  34. Cognitive Function2▲ 11×3 topics
  35. Enteral Nutrition2▲ 79×1 topic
  36. Nutrition Support Therapy2▲ 79×1 topic
  37. Chronic Kidney Disease1▲ 7.4×5 topics
  38. Elderly1▲ 7.2×4 topics
  39. Ethical Decision Making1▲ 56×1 topic
  40. Moral Identity1▲ 73×1 topic

Which research topics does Otsuka Pharmaceutical (Spain) publish most on?

By volume in 2022–2025: Health Systems, Economic Evaluations, Quality of Life, Schizophrenia research and treatment, Attention Deficit Hyperactivity Disorder and Clinical Nutrition and Gastroenterology.

Health Systems, Economic…3Health Systems, Economic Evaluations, Quality of Life: 3 fractional worksSchizophrenia research and treatment: 3 fractional worksAttention Deficit Hyperactivity Disorder: 2 fractional worksClinical Nutrition and Gastroenterology: 2 fractional worksEthics in Business and Education: 1 fractional worksDementia and Cognitive Impairment Research: 1 fractional worksDiet and metabolism stud…1Diet and metabolism studies: 1 fractional worksThyroid Cancer Diagnosis and Treatment: 1 fractional worksHealthcare Decision-Making and Restraints: 1 fractional worksPharmaceutical studies and practices: 1 fractional works
Economics and EconometricsPsychiatry and Mental healthNutrition and DieteticsInformation Systems and Management4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 3 works
  2. 2 Schizophrenia research and treatment Psychiatry and Mental health 3 works
  3. 3 Attention Deficit Hyperactivity Disorder Psychiatry and Mental health 2 works
  4. 4 Clinical Nutrition and Gastroenterology Nutrition and Dietetics 2 works
  5. 5 Ethics in Business and Education Information Systems and Management 1 works
  6. 6 Dementia and Cognitive Impairment Research Psychiatry and Mental health 1 works
  7. 7 Diet and metabolism studies Physiology 1 works
  8. 8 Thyroid Cancer Diagnosis and Treatment Endocrinology, Diabetes and Metabolism 1 works
  9. 9 Healthcare Decision-Making and Restraints Clinical Psychology 1 works
  10. 10 Pharmaceutical studies and practices Pediatrics, Perinatology and Child Health 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available59.8%not open40.2%

World: 28% of research is openly available.

with international co-authors73.4%domestic only26.6%

World: 19% is written across borders.

How has Otsuka Pharmaceutical (Spain)'s research output changed?

Output in 2018–2022 was 8% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Barcelona

All research institutions in Barcelona

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.